Despite a voluminous literature on potential protein biomarkers and a compelling need for
diagnostic tests based on biomarkers to detect cancers at much earlier, more treatable …

In recent years, many advances have been made in the field of proteomics. The use of high-
throughput methods for analyzing complex proteomes, in particular SELDI mass …

Cancer proteomics is an exciting field that is witnessing many new developments in recent
years. It is hoped that these advances will result in decreased cancer death rates, which …

Simple Summary The traditional approach in identifying cancer related protein biomarkers
has focused on evaluation of a single peptide/protein in tissue or circulation. At best, this …

Proteome analysis promises to be valuable for the identification of tissue and serum
biomarkers associated with human malignancies. In addition, proteome technologies offer …

The enormous progress in proteomics, enabled by recent advances in MS (mass
spectrometry), has brought protein analysis back into the limelight of cancer research …

The ultimate goal of cancer proteomics is to adapt proteomic technologies for routine use in
clinical laboratories for the purpose of diagnostic and prognostic classification of disease …

The ability of physicians to effectively treat and cure cancer is directly dependent on their
ability to detect cancers at their earliest stages. Proteomic analyses of early-stage cancers …

Proteomics is more than just a list-generating exercise where increases or decreases in
protein expression are identified. Proteomic technologies will ultimately characterize …

Strategies to achieve personalized medicine and improve public health encompass
assessment of an individual's risk for disease, early detection, and molecular classification of …